These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 9469226)
21. Identification and characterization of the enzymes responsible for the metabolism of the non-steroidal anti-inflammatory drugs, flunixin meglumine and phenylbutazone, in horses. Knych HK; Finno CJ; Baden R; Arthur RM; McKemie DS J Vet Pharmacol Ther; 2021 Jan; 44(1):36-46. PubMed ID: 32757313 [TBL] [Abstract][Full Text] [Related]
22. Preliminary studies of offspring exposure to phenylbutazone and ivermectin during the perinatal period in a Holstein cow-calf model. Chamberlain PL; Fowler BA; Sexton MJ; Peggins JO; Bredow Jv Toxicol Appl Pharmacol; 2003 Mar; 187(3):198-208. PubMed ID: 12662903 [TBL] [Abstract][Full Text] [Related]
23. Rapid screening and confirmation for drugs and metabolites in racing animals by tandem mass spectrometry. Brotherton HO; Yost RA Am J Vet Res; 1984 Nov; 45(11):2436-40. PubMed ID: 6524741 [TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic interactions between repeated dose phenylbutazone and gentamicin in the horse. Whittem T; Firth EC; Hodge H; Turner K J Vet Pharmacol Ther; 1996 Dec; 19(6):454-9. PubMed ID: 8971674 [TBL] [Abstract][Full Text] [Related]
25. Phenylbutazone blood and urine concentrations, pharmacokinetics, and effects on biomarkers of inflammation in horses following intravenous and oral administration of clinical doses. Knych HK; Arthur RM; McKemie DS; Seminoff K; Hamamoto-Hardman B; Kass PH Drug Test Anal; 2019 Jun; 11(6):792-803. PubMed ID: 30499176 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of intravenous and intragastric cimetidine in horses. I. Effects of intravenous cimetidine on pharmacokinetics of intravenous phenylbutazone. Sams RA; Gerken DF; Dyke TM; Reed SM; Ashcraft SM J Vet Pharmacol Ther; 1997 Oct; 20(5):355-61. PubMed ID: 9350255 [TBL] [Abstract][Full Text] [Related]
27. Effects of meloxicam and phenylbutazone on renal responses to furosemide, dobutamine, and exercise in horses. Raidal SL; Hughes KJ; Charman AL; Nielsen SG; Phillips JK; Noble GK Am J Vet Res; 2014 Jul; 75(7):668-79. PubMed ID: 24959734 [TBL] [Abstract][Full Text] [Related]
28. Determination of phenylbutazone and oxyphenbutazone in plasma and urine samples of horses by high-performance liquid chromatography and gas chromatography-mass spectrometry. Neto LM; Andraus MH; Salvadori MC J Chromatogr B Biomed Appl; 1996 Apr; 678(2):211-8. PubMed ID: 8738024 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of the potential for interference by dimethyl sulfoxide (DMSO) in drug detection in racing animals. Craig AM; Blythe LL; Appell LH; Slizeski ML J Vet Pharmacol Ther; 1987 Dec; 10(4):298-304. PubMed ID: 3437494 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of phenylbutazone in llamas following single intravenous and oral doses. Navarre CB; Ravis WR; Nagilla R; Simpkins A; Duran SH; Pugh DG J Vet Pharmacol Ther; 2001 Jun; 24(3):227-31. PubMed ID: 11442803 [No Abstract] [Full Text] [Related]
31. Effects of phenylbutazone on gene expression of cyclooxygenase-1 and -2 in the oral, glandular gastric, and bladder mucosae of healthy horses. Nieto JE; Aleman M; Anderson JD; Fiack C; Snyder JR Am J Vet Res; 2012 Jan; 73(1):98-104. PubMed ID: 22204294 [TBL] [Abstract][Full Text] [Related]
32. Effects of oral administration of phenylbutazone to horses on in vitro articular cartilage metabolism. Beluche LA; Bertone AL; Anderson DE; Rohde C Am J Vet Res; 2001 Dec; 62(12):1916-21. PubMed ID: 11763181 [TBL] [Abstract][Full Text] [Related]
33. Disposition of human drug preparations in the horse. I. Rectally administered indomethacin. Delbeke FT; Debackere M; Vynckier L J Vet Pharmacol Ther; 1991 Jun; 14(2):145-9. PubMed ID: 1920602 [TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic and pharmacodynamic studies on phenylbutazone and oxyphenbutazone in goats. Cheng Z; Welsh E; Nolan A; McKellar QA Vet Rec; 1997 Jan; 140(2):40-3. PubMed ID: 9123796 [TBL] [Abstract][Full Text] [Related]
35. Phenylbutazone and its metabolites in plasma and urine of thoroughbred horses: population distributions and effects of urinary pH. Houston T; Chay S; Woods WE; Combs G; Kamerling S; Blake JW; Edmundson AG; Vessiney R; Tobin T J Vet Pharmacol Ther; 1985 Jun; 8(2):136-49. PubMed ID: 4020945 [TBL] [Abstract][Full Text] [Related]
36. Effectiveness of administration of phenylbutazone alone or concurrent administration of phenylbutazone and flunixin meglumine to alleviate lameness in horses. Keegan KG; Messer NT; Reed SK; Wilson DA; Kramer J Am J Vet Res; 2008 Feb; 69(2):167-73. PubMed ID: 18241011 [TBL] [Abstract][Full Text] [Related]
37. Use of phenylbutazone in competitions. Vogel C Vet Rec; 1981 Mar; 108(12):248. PubMed ID: 7269169 [No Abstract] [Full Text] [Related]
38. Phenylbutazone and equine research. Coles G Vet Rec; 2005 Mar; 156(10):327-8. PubMed ID: 15786928 [No Abstract] [Full Text] [Related]
39. Quantification and validation of nine nonsteroidal anti-inflammatory drugs in equine urine using gas chromatography-mass spectrometry for doping control. Göktaş EF; Kabil E; Arıöz F Drug Test Anal; 2020 Aug; 12(8):1065-1077. PubMed ID: 32449838 [TBL] [Abstract][Full Text] [Related]
40. [Doping problems in horse sports--pharmacokinetics of selected antiphlogistics/analgesics relevant to doping]. Klaus AM; Hapke HJ Dtsch Tierarztl Wochenschr; 1994 Aug; 101(8):331-8. PubMed ID: 7924979 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]